-
1
-
-
0005602615
-
-
J. Bremer, Carnitine metabolism and function. Ann. Rev. Physiol. 63 (1983) 1420-80.
-
-
-
-
2
-
-
0005599981
-
-
P.R. Borum, Carnitine. Ann. Rev. Nutr. 3 (1983) 233-59.
-
-
-
-
3
-
-
0005562729
-
-
L.L. Bieber, Carnitine. Ann. Rev. Biochem. 57 (1988) 261-83.
-
-
-
-
4
-
-
0005617174
-
-
J. Bahl, T. Navin, A. Manian, R. Bressler, Carnitine transport in isolated adult rat heart myocytes and the effect of 7,8-diOH chlorpromazine. Circ. Res. 48 (1981) 378-85.
-
-
-
-
5
-
-
0005606563
-
-
C. Cantrell, P.R. Borum, Identification of a cardiac binding protein. J. Biol. Chem. 257 (1982) 10599-604.
-
-
-
-
6
-
-
0005562730
-
-
C.J. Rebouche, Carnitine movement across muscle cell membranes. Studies in isolated rat muscle. Biochim. Biophys. Acta. 471 (1977) 145-55.
-
-
-
-
7
-
-
0005624093
-
-
J.H. Willner, S. Ginsburg, S. Dimauro, Active transport of carnitine into skeletal muscle. Neurology 28 (1978) 721-4.
-
-
-
-
8
-
-
0005581899
-
-
A.G. Engel, C. Angelini, Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 179 (1973) 899-902.
-
-
-
-
9
-
-
0005607085
-
-
C.J. Rebouche, D.J. Paulson, Carnitine metabolism and function in humans. Ann. Rev. Nutr. 6 (1986) 41-66.
-
-
-
-
10
-
-
0005565898
-
-
B. Melegh, J. Kerner, L.L. Bieber, Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem. Pharm. 36 (1987) 3405-9.
-
-
-
-
11
-
-
0005599982
-
-
B. Melegh, J. Kerner, V. Jaszai, L.L. Bieber, Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate. Biochem. Med. Met. Biol. 43 (1990) 30-8.
-
-
-
-
12
-
-
0005601837
-
-
K. Abrahamsson, B.O. Eriksson, E. Holme, U. Jodal, A. Jonsson, S. Lindstedt, Pivalic acid-induced carnitine deficiency and physical exercise in humans. Metabolism 45 (1996) 1501-7.
-
-
-
-
13
-
-
0005562731
-
-
E. Holme, C.E. Jacobson, I. Nordin, J. Greter, S. Lindstedt, B. Kristiansson, U. Jodal, Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2 (1989) 469-72.
-
-
-
-
14
-
-
0005618506
-
-
A.A. Sinkula, S.H. Yalkowsky, Rationale for design of biologically reversible drug derivatives: prodrugs. J. Pharm. Sci. 64 (1975) 181-210.
-
-
-
-
15
-
-
84862708640
-
-
14C. Oyo Yakuri 17 (1979) 923-33.
-
-
-
-
16
-
-
0005618508
-
-
S. Vickers, C.A.H. Duncan, S.D. White, H.G. Ramjit, J.L. Smith, R.W. Walker, H. Flynn, B.H. Arison, Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica 15 (1985) 453-8.
-
-
-
-
17
-
-
0005558966
-
-
P.B. Bianchi, A.T. Davis, Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats. J. Nutr. 121 (1991) 2029-36.
-
-
-
-
18
-
-
0005601838
-
-
L.J. Ruff, E.P. Brass, Metabolic effects of pivalate in isolated rat hepatocytes. Toxicol. Appl. Pharm. 110 (1991) 295-302.
-
-
-
-
19
-
-
0005562865
-
-
Q.N. Diep, T. Bohmer, S. Skrede, Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat. Biochim. Biophys. Acta. 1234 (1995) 65-70.
-
-
-
-
20
-
-
0005636054
-
-
D.D. Dziewiatkowski, H.B. Lewis, The metabolism of trimethylacetic (pivalic) and tertiary butylacetic acid. New examples of conjugation with glucuronic acid. J. Biol. Chem. 158 (1945) 77-87.
-
-
-
-
21
-
-
0005617176
-
-
T.L. Broderick, S. Christos, B.A. Wolf, D. DiDomenico, A. Shug, D. Paulson, Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency. Metabolism 44 (1995) 499-505.
-
-
-
-
22
-
-
0005530034
-
-
Q.N. Diep, T. Bohmer, L. Schjerven, Reduced carnitine and ketogenesis in the pivampicillin treated rat. Bioch. Pharm. 44 (1992) 1226-8.
-
-
-
-
23
-
-
0005581901
-
-
G.S. Morris, Q. Zhou, B.A. Wolf, S.C. Christos, D.F. DiDomenica, A.L. Shug, D.J. Paulson, Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacity. Life Sci. 57 (1995) 2237-44.
-
-
-
-
24
-
-
0005607086
-
-
B. Wittels, R. Bressler, Biochemical lesion of diphtheria toxin in the heart. J. Clin. Invest. 43 (1964) 630-7.
-
-
-
-
25
-
-
84862711054
-
-
B.Z. Simkhovich, Z. Shutenko, D.V. Meirena, K.B. Khagi, et al., 3-(2,2,2-Trimethylhydrazinium) proprionate (THP)-A novel γ-butyrobetaine hydorxylase inhibitor with cardioprotective properties. Bioch. Pharm. 37 (1988) 195-202.
-
-
-
-
26
-
-
0005522834
-
-
O.J. Heinonen, J. Takala, Moderate carnitine depletion and long-chain fatty acid oxidation, exercise capacity, and nitrogen balance in the rat. Pediatr. Res. 36 (1994) 288-92.
-
-
-
-
27
-
-
0005607087
-
-
N. Asaka, Y. Muranaka, T. Kirimoto, H. Miyake, Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts. Fundam. Clin. Pharmacol. 12 (1998) 158-63.
-
-
-
-
28
-
-
0005531323
-
-
H. Nakajima, N. Kodo, F. Inoue, Z. Kizaki, S. Nukina, A. Kinugasa, T. Sawada, Pivalate affects carnitine status but causes no severe metabolic changes in rat liver. J. Nutr. 126 (1996) 1683-7.
-
-
-
-
29
-
-
84862712500
-
-
P.B. Bianchi, A.T. Davis, β-hydroxybutyrate oxidation is reduced and hepatic balance of ketone bodies and free fatty acids is unaltered in carnitine-depleted, pivalate-greated rats. J. Nutr. 126 (1996) 2867-72.
-
-
-
-
30
-
-
84862713486
-
-
M. Tsoko, F. Beauseigneur, J. Gresti, I. Niot, et al. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a γ-butyrobetaine hydroxylase inhibitor. Bioch. Pharm. 49 (1995) 1403-10.
-
-
-
-
31
-
-
0005566761
-
-
P. Bianchi, D. Lehotay, A.T. Davis, Carnitine supplementation ameliorates the steatosis and ketosis induced by pivalate in rats. J. Nutr. 126 (1996) 2873-9.
-
-
-
-
32
-
-
0005562733
-
-
P.R. Borum, C. York, S. Bennett, Carnitine concentration of red blood cells. Am. J. Clin. Nutr. 41 (1985) 653-6.
-
-
-
-
33
-
-
0005522289
-
-
B. Melegh, B. Sumegi, A.D. Sherry, Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man. Xenobiotica 23 (1993) 1255-61.
-
-
-
-
34
-
-
0005594011
-
-
H.S. Sheratt, Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates. Biochem. Soc. Trans. 13 (1985) 856-8.
-
-
-
-
35
-
-
0005522835
-
-
M. Tomomura, A. Tomomura, M.A. Dewan, M. Horiuchi, et al., Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood. J. Biochem. 121 (1997) 172-7.
-
-
-
-
36
-
-
0005582066
-
-
G. Cederblad, S. Lindstedt, Metabolism of labeled carnitine in the rat. Arch. Biochem. Biophys. 175 (1976) 173-80.
-
-
-
|